(Q37310816)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957942%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

review article

1 reference

title

Immunization in Alzheimer's disease: naïve hope or realistic clinical potential? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957942%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

0 references

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957942%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Ralph Martins

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957942%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

J K Foster

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957942%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

K A Bates

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957942%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

language of work or name

English

0 references

publication date

28 October 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957942%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957942%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957942%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957942%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

239-251

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957942%20AND%20SRC:MED&resulttype=core&format=json

Current pharmacotherapy for Alzheimer's disease

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

General risk factors for dementia: a systematic evidence review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

[Risk factors in Alzheimer's dementia]

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Stimulation of endogenous neurogenesis by anti-EFRH immunization in a transgenic mouse model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Current concepts and future prospects for Alzheimer disease vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

The memory deficits in Alzheimer-type dementia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Lessons from the AN 1792 Alzheimer vaccine: lest we forget.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Combination therapy of donepezil and vitamin E in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Intravenous immunoglobulin enhances the clearance of fibrillar amyloid-beta peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Cerebral hemorrhage after passive anti-Abeta immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Passive immunization against beta-amyloid peptide protects central nervous system (CNS) neurons from increased vulnerability associated with an Alzheimer's disease-causing mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Modulation of microglial activation state following passive immunization in amyloid depositing transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Human monoclonal antibodies against amyloid-beta from healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

The F(ab)'2 fragment of an Abeta-specific monoclonal antibody reduces Abeta deposits in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Monoclonal antibodies that target pathological assemblies of Abeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Meningoencephalitis associated with passive immunization of a transgenic murine model of Alzheimer's amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

HSV amplicon-mediated Abeta vaccination in Tg2576 mice: differential antigen-specific immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Is there a future for vaccination as a treatment for Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

7 January 2021

Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

7 January 2021

Anti-Abeta antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

7 January 2021

Research criteria for the diagnosis of Alzheimer's disease: genetic risk factors, blood biomarkers and olfactory dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FMP.2008.115

7 January 2021

Identifiers

DOI

10.1038/MP.2008.115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18957942%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference